The RayPlex Pembrolizumab (Keytruda®) ADA kit is a cytometric bead assay to quantitatively measure Pembrolizumab (Keytruda®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Ranibizumab (Lucentis®) ADA kit is a cytometric bead assay to quantitatively measure Ranibizumab (Lucentis®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Rituximab ADA kit is a cytometric bead assay that quantitatively detects anti-drug antibodies by flow cytometry. Suitable for serum and plasma.
The RayPlex Sarilumab (Kevzara®) ADA kit is a cytometric bead assay to quantitatively measure Sarilumab (Kevzara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Sarilumab (Kevzara®) ADA kit is a cytometric bead assay to quantitatively measure Sarilumab (Kevzara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Tocilizumab (Actemra®) ADA kit is a cytometric bead assay to quantitatively measure Tocilizumab (Actemra®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Tocilizumab (Actemra®) ADA kit is a cytometric bead assay to quantitatively measure Tocilizumab (Actemra®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Bevacizumab (Avastin®) DA kit is a cytometric bead assay to quantitatively measure Bevacizumab (Avastin®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Cetuximab (Erbitux®) DA kit is a cytometric bead assay to quantitatively measure Cetuximab (Erbitux®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.